Journal of Kerman University of Medical Sciences

Current Issue

By Issue

By Author

Author Index

Keyword Index

About Journal

Aims and Scope

JKMU Ethical Policies

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

News

Metric

The relationship between levothyroxine and gestational weight gain in subclinical hypothyroidism compared to euthyroid individuals

Articles in Press

Document Type : Original Article

Authors

1 Student research committee, Najafabad Branch, Islamic Azad University, Najafabad, Iran

2 Department of Statistics and Information Technology, Isfahan University of Medical Sciences, Isfahan, Iran

3 Shahid Beheshti Ardestan Hospital, Isfahan University of Medical Sciences, Isfahan, Iran

4 Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran

5 Social Determinants of Health Research Center, Department of Health Education and Promotion, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd. Iran

6 Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Introduction: Untreated subclinical hypothyroidism (SCH) can lead to complications during pregnancy. One significant concern associated with pregnancy is excessive weight gain. Given the link between hypothyroidism and obesity, we aimed to investigate the relationship between the dose of levothyroxine and gestational weight gain (GWG), for which we did not find any reports. Additionally, we measured the differences in GWG between women with and without SCH who were monitored until the end of their pregnancies.
Methods: Primiparous women (N = 245) were selected using cluster sampling and entered into a prospective cohort study. Subclinical hypothyroidism (SCH) was determined so that participants could be divided into two groups, with and without SCH, and followed until the end of pregnancy. Levothyroxine dose was used as an independent variable, and maternal weights at 6–10, 18, 26, 33, 36 weeks, and at term (37–41) were determined as dependent (outcome) variables. Thyroid-stimulating hormone (TSH) levels during the first trimester and pre-pregnancy body mass index (BMI) were also recorded as key influencing variables. Data were collected via interviews and prenatal records from community health centers. Ten specialists confirmed the face validity of the questionnaire. To enhance reliability, all interviewers received training under the same conditions. Additionally, since the information was recorded using fixed and standardized forms, the reliability of the data had already been established.
Results: After adjusting for time (weight measurement in different weeks of pregnancy) and pre-pregnancy BMI, the average dose of levothyroxine was found to be correlated with gestational weight gain (GWG) (β = 0.036, SE = 0.016, p = 0.025). Additionally, there were no significant differences in total GWG between individuals with subclinical hypothyroidism (SCH) and euthyroid concerning their levothyroxine use (yes or no) (β = 0.812, SE = 0.997, p = 0.415).
Conclusion: We found a positive correlation between levothyroxine dosage and weight gain during pregnancy, which is a valuable result. Additionally, total weight gain in participants with subclinical hypothyroidism treated with levothyroxine did not differ statistically from that of euthyroid subjects.

Keywords

Main Subjects

References
1)         Gottwald-Hostalek U, Kahaly GJ. Optimizing levothyroxine treatment for subclinical hypothyroidism during pregnancy. Curr Med Res Opin. 2024 Jan 2;40(1):43-9. doi: 10.1080/03007995.2023.2276120.
2)         Solha ST, Mattar R, Teixeira PD, Chiamolera MI, Maganha CA, Zaconeta AC, Souza RT. Screening, diagnosis and management of hypothyroidism in pregnancy: Number 10–October 2022. Rev Bras Ginecol Obstet. 2022;44(10):999-1009. doi: 10.1055/s-0042-1758490.
3)         Zhou Y, Wang Y, Yu T, Li Y, Mi M, Su J, Ge J. Subclinical hypothyroidism during pregnancy and the impact of levothyroxine therapy on pregnancy outcomes in women. PeerJ. 2025 Apr 28;13:e19343,  Leng T, Li X, Zhang H. Levothyroxine treatment for subclinical hypothyroidism improves the rate of live births in pregnant women with recurrent pregnancy loss: a randomized clinical trial. Gynecological Endocrinology. 2022 Jun 3;38(6):488-94. doi: 10.1080/09513590.2022.2063831.
4)         Rao M, Zeng Z, Zhou F, Wang H, Liu J, Wang R, Wen Y, Yang Z, Su C, Su Z, Zhao S. Effect of levothyroxine supplementation on pregnancy loss and preterm birth in women with subclinical hypothyroidism and thyroid autoimmunity: a systematic review and meta-analysis. Human reproduction update. 2019 May 1;25(3):344-61. doi: 10.1093/humupd/dmz003.
5)          Goodarzi-Khoigani M, Aminorroaya A, Mohammadi R. Effect of Levothyroxine Therapy on Gestational Hypertension and Pre-Eclampsia in Pregnant Women with Subclinical Hypothyroidism, Hypothyroidism, and Thyroid Autoimmunity: A Systematic Review and Meta-analysis. Cardiovascular & hematological disorders drug targets. Cardiovascular & Hematological Disorders-Drug Targets, 2025; 25: 2-20. doi: 10.2174/011871529X324722250207072454.
6)         Goławski K, Giermaziak W, Ciebiera M, Wojtyła C. Excessive gestational weight gain and pregnancy outcomes. J Clin Med. 2023 Apr 29;12(9):3211-19. doi: 10.3390/jcm12093211.
7)         Xu R, Huang F, Zhang S, Lv Y, Liu Q. Thyroid function, body mass index, and metabolic risk markers in euthyroid adults: a cohort study. BMC endocrine disorders. 2019 Dec;19:1-9. doi: 10.1186/s12902-019-0383-2.
8)         Zhou B, Chen Y, Cai WQ, Liu L, Hu XJ. Effect of gestational weight gain on associations between maternal thyroid hormones and birth outcomes. Frontiers in Endocrinology. 2020 Sep 3;11:610. doi: 10.3389/fendo.2020.00610.
9)     Han L, Ma Y, Liang Z, Chen D. Laboratory characteristics analysis of the efficacy of levothyroxine on subclinical hypothyroidism during pregnancy: a single-center retrospective study. Bioengineered. 2021 Jan 1;12(1):4183-90. doi: 10.1080/21655979.2021.1955589.
10)       Chen L, Wang J, Jiang P, Ren F, Lei X, Guo H. Alteration of the colostrum whey proteome in mothers with gestational hypothyroidism. Plos one. 2018 Oct 17;13(10):e0205987. doi: 10.1371/journal.pone.0205987.
11)       Ju R, Lin L, Long Y, Zhang J, Huang J. Clinical efficacy of therapeutic intervention for subclinical hypothyroidism during pregnancy. Genet Mol Res. 2016 Nov 21;15(4):4-8. doi: 10.4238/gmr15049019.
12)       Alptekin H, Alptekin N, Isik H, Tanrikulu Y, Sahin E. Maternal Hipotiroidinin Fetal Umblikal Kord Beyin Kaynakli Nörotrofik Faktör Düzeylerine Etkisi/The Effect of Maternal Hypothyroidism on Fetal Umbilical Cord Brain-Derived Neurotrophic Factor Levels. Dicle Tip Dergisi. 2016 Mar 1;43(1):107. doi: 10.5798/diclemedj.0921.2016.01.0647.
13)       Zhao L, Jiang G, Tian X, Zhang X, Zhu T, Chen B, Wang Y, Ma Q. Initiation timing effect of levothyroxine treatment on subclinical hypothyroidism in pregnancy. Gynecol Endocrinol. 2018 Oct 3;34(10):845-8. doi: 10.1080/09513590.2018.1451836.
14)          Goodarzi-Khoigani M, Ardakani TS, Aram FA, Khoshhali M, Mardanian F, Ardian N. The effect of Internet-based nutrition education according to Pender’s health promotion model on gestational weight gain: Study protocol for a randomized controlled clinical trial. Journal of Education and Health Promotion. 2024 Jul 1;13(1):259. doi: 10.4103/jehp.jehp_926_23
15)     Mohammadi R, Goodarzi-Khoigani M, Allameh Z, Mahmoodabad SS, Moghadam MH, Nadjarzadeh A, Mardanian F. Association between socioeconomic status and homeostasis model assessment-insulin resistance index and mediating variables at the first trimester of pregnancy. Iran J Nurs Midwifery Res. 2022 Mar 1;27(2):166-8. doi: 10.4103/ijnmr.ijnmr_451_20.
16)        Pustilnik E, Schwarzstein D, Feldman R, Mancinelli L, Paladini L, Pellizzón NA, Stieben LA. The influence of age and body weight on levothyroxine replacement dosage to achieve euthyroidism in patients with primary hypothyroidism. Endocrinol Diabetes Nutr (Engl Ed). 2021 Oct 1;68(8):542-7. doi: 10.1016/j.endien.2021.11.014.
17)         Javed Z, Sathyapalan T. Levothyroxine treatment of mild subclinical hypothyroidism: a review of potential risks and benefits. Ther Adv Endocrinol Metab. 2016 Feb;7(1):12-23.doi: 10.1177/2042018815616543.
18)   Alfaifi HH, Altowairgi MA, Algethami RG, Altowairqi AH, Althomali HD, Almalki OM. Effectiveness of bariatric surgery for improving thyroid function and reducing levothyroxine dose in patients with obesity and overt hypothyroidism. Cureus. 2023 May;15(5): e38780. doi: 10.7759/cureus.38780.
19)        Bohlega B, Zahedi A, Tomlinson G, Feig DS. Weight‐based thyroid dosing vs fixed dosing during pregnancy for subclinical hypothyroidism: a retrospective cohort study. Clin Endocrinol. 2022 Feb;96(2):263-9. doi: 10.1111/cen.14488.
20)        Mardanian F, Goodarzi-Khoigani M, Mahmoodabad SS, Moghadam MH, Nadjarzadeh A, Feizi A, Allameh Z, Molavi S. The association between serum TSH concentration whithin the normal range and nutritional status in euthyroid pregnant women at the first trimester of gestation. J Res Med Sci. 2021 Jan 1;26(1):93. doi: 10.4103/jrms.JRMS_780_20.
21)           Ezzeddine D, Ezzeddine D, Hamadi C, Abbas HA, Nassar A, Abiad M, Ghazeeri G. Prevalence and correlation of hypothyroidism with pregnancy outcomes among lebanese women. J Endocr Soc. 2017 May 1;1(5):415-22. doi: 10.1210/js.2017-00014.
22)          LIU J, Xie X, García-Patterson A, Asla Q, Sardà H, Chico A, Adelantado JM, Urgell E, Corcoy R. Weight gain according to Institute of Medicine 2009 in pregnant women with thyroid disorders as per their thyroid status in each trimester. doi: 10.1007/s00404-023-07279-z.
23)       Biondi B, Kahaly GJ, Robertson RP. Thyroid dysfunction and diabetes mellitus: two closely associated disorders. Endocr Rev. 2019 Jun;40(3):789-824. doi: 10.1210/er.2018-00163.
24)      Pearce EN. Thyroid hormone and obesity. Current Opinion in Endocrinology, Diabetes and Obesity. 2012 Oct 1;19(5):408-13. doi: 10.1097/MED.0b013e328355cd6c.
25)           Al Bishi L. Effect of Levothyroxine Therapy on Body Mass and Obesity in Overt and Subclinical Hypothyroidism. IJPRAS. 2023 Jul 1;12(3). doi.org/10.51847/N2XEdTNvPe.
26)           Sayin I, Erkan AF, Ekici B, Kutuk U, Corakci A, Tore HF. Thickening of the epicardial adipose tissue can be alleviated by thyroid hormone replacement therapy in patients with subclinical hypothyroidism. Kardiol Pol. 2016;74(12):1492-8. doi: 10.5603/KP.a2016.0053.
27)    Samuels MH, Kolobova I, Niederhausen M, Purnell JQ, Schuff KG. Effects of altering levothyroxine dose on energy expenditure and body composition in subjects treated with LT4. The J Clin Endocrinol Metab. 2018 Nov;103(11):4163-75. doi: 10.1210/jc.2018-01203.
28)       Harsini AR, Mohajeri-Tehrani MR, Sajjadi-Jazi SM, Naeini F, Valisoltani N, Sadeghi E, Mohammadi H, Hosseini S. Are resting metabolic rate and clinical symptoms affected by variation of serum thyroid stimulating hormone levels within the normal range in healthy and women with hypothyroidism? A case–control study. Clin Nutr ESPEN. 2024 Jun 1;61:71-8. doi: 10.1016/j.clnesp.2024.02.030.
 
Journal of Kerman University of Medical Sciences

Articles in Press, Accepted Manuscript
Available Online from 02 November 2025
Files
Share
How to cite
Statistics